OTCPK:MEDVF - Post by User
Post by
Sarb99on May 06, 2020 12:40am
233 Views
Post# 30991257
QuestCap & MTJR Partnership Signs Sales Agreement for 500000
QuestCap & MTJR Partnership Signs Sales Agreement for 500000TORONTO, May 06, 2020 (GLOBE NEWSWIRE) -- QuestCap Inc. (“QuestCap” or the “Company”) (CSE:QSC; FRA:34C1) is pleased to announce the first commercial sales agreement received for antibody tests by commercial partner and distributor MTJR. QuestCap and MTJR have agreed to supply 500,000 PCL COVID-19 IgG/IgM Antibody tests to BioCorp Clinical Laboratory (“BioCorp”), a high-complexity laboratory based in California. The partnership will provide 50,000 tests per week for 10 weeks with an option to extend. As part of the profit-sharing agreement with MTJR, QuestCap will receive 40% of the proceeds. QuestCap has completed due diligence on PCL’s production capacity and is satisfied they will be able to supply the quality and quantity of tests required. https://www.stockwatch.com/News/Item?bid=Z-C%3aQSC-2900862&symbol=QSC®ion=C